These images are provided for non-commercial use under a Creative Commons License (BY-NC-ND). To license a high resolution version, please contact our image library who will discuss fees, terms and waivers.
Download this imageCreative commons explained - what it means, how you can use our's and other people's content.
?Vaccinium corymbosum
Draughtsman: Cockerell, The Hon. Lady
History note: Sir Charles Cockerell; Gerald Ponsonby; The Hon. Henry Rogers Broughton, 2nd Lord Fairhaven
Method of acquisition: Bequeathed (1973) by Broughton, Henry Rogers, Major the Hon.
Watercolour
Bodycolour
White bodycolour
Graphite
Gum arabic
Support composed of card Height 364 mm Width 259 mm
Watercolour : Watercolour, bodycolour including white with gum Arabic over slight traces of graphite on card
Accession number: PD.119-1973.34
Primary reference Number: 81276
Stable URI
Owner or interested party:
The Fitzwilliam Museum
Associated department:
Paintings, Drawings and Prints
This record can be cited in the Harvard Bibliographic style using the text below:
The Fitzwilliam Museum (2024) "?Vaccinium corymbosum" Web page available at: https://collection.beta.fitz.ms/id/object/81276 Accessed: 2024-11-25 00:12:31
To cite this record on Wikipedia you can use this code snippet:
{{cite web|url=https://collection.beta.fitz.ms/id/object/81276
|title=?Vaccinium corymbosum
|author=The Fitzwilliam Museum|accessdate=2024-11-25 00:12:31|publisher=The
University of Cambridge}}
To call these data via our API (remember this needs to be authenticated) you can use this code snippet:
https://collection.beta.fitz.ms/api/v1/objects/object-81276
To use this as a simple code embed, copy this string:
<div class="text-center">
<figure class="figure">
<img src="https://data.fitzmuseum.cam.ac.uk/imagestore/pdp/pdp34/PD_119_1973_34.jpg"
alt="?Vaccinium corymbosum"
class="img-fluid" />
<figcaption class="figure-caption text-info">?Vaccinium corymbosum</figcaption>
</figure>
</div>
Updates about future exhibitions and displays, family activities, virtual events & news. You'll be the first to know...
